About this Journal Submit a Manuscript Table of Contents
International Journal of Peptides
Volume 2010 (2010), Article ID 567343, 7 pages
http://dx.doi.org/10.1155/2010/567343
Review Article

Ghrelin in Chronic Kidney Disease

Division of Pediatric Nephrology, Department of Pediatrics, University of California San Diego, 9500 Gilman Drive, Mail code no. 0634, La Jolla, CA 92093-0634, USA

Received 14 November 2009; Accepted 8 February 2010

Academic Editor: Hubert Vaudry

Copyright © 2010 Wai W. Cheung and Robert H. Mak. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Mak, W. Cheung, R. D. Cone, and D. L. Marks, “Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease,” Pediatric Nephrology, vol. 20, no. 3, pp. 427–431, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. H. Mak and W. Cheung, “Energy homeostasis and cachexia in chronic kidney disease,” Pediatric Nephrology, vol. 21, no. 12, pp. 1807–1814, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. H. Mak and W. Cheung, “Therapeutic strategy for cachexia in chronic kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 26, no. 6, pp. 542–546, 2007. View at Scopus
  4. R. H. Mak, W. Cheung, R. D. Cone, and D. L. Marks, “Leptin and inflammation-associated cachexia in chronic kidney disease,” Kidney International, vol. 69, no. 5, pp. 794–797, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. W. Schwartz, S. C. Woods, D. Porte, R. J. Seeley, and D. G. Baskin, “Central nervous system controls of food intake,” Nature, vol. 418, pp. 595–597, 2002.
  6. W. Cheung, P. X. Yu, B. M. Little, R. D. Cone, D. L. Marks, and R. H. Mak, “Role of leptin and melanocortin signaling in uremia-associated cachexia,” Journal of Clinical Investigation, vol. 115, no. 6, pp. 1659–1665, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. W. W. Cheung, H.-J. Kuo, S. Markison, et al., “Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice,” Journal of the American Society of Nephrology, vol. 18, no. 9, pp. 2517–2524, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, “Ghrelin is a growth-hormone-releasing acylated peptide from stomach,” Nature, vol. 402, no. 6762, pp. 656–660, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kojima and K. Kangawa, “Ghrelin: structure and function,” Physiological Reviews, vol. 85, no. 2, pp. 495–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Dickson and S. M. Luckman, “Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6,” Endocrinology, vol. 138, no. 2, pp. 771–777, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. A. K. Hewson, L. Y. C. Tung, D. W. Connell, L. Tookman, and S. L. Dickson, “The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic,” Diabetes, vol. 51, no. 12, pp. 3412–3419, 2002. View at Scopus
  12. E. Jerlhag, E. Egecioglu, S. L. Dickson, M. Andersson, L. Svensson, and J. A. Engel, “Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward,” Addiction Biology, vol. 11, no. 1, pp. 45–54, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Arvat, L. Di Vito, F. Broglio, et al., “Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans,” Journal of Endocrinological Investigation, vol. 23, no. 8, pp. 493–495, 2000. View at Scopus
  14. V. Locatelli, E. Bresciani, I. Bulgarelli, et al., “Ghrelin in gastroenteric pathophysiology,” Journal of Endocrinological Investigation, vol. 28, no. 9, pp. 843–848, 2005. View at Scopus
  15. H. Hosoda, M. Kojima, H. Matsuo, and K. Kangawa, “Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor,” The Journal of Biological Chemistry, vol. 275, no. 29, pp. 21995–22000, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Woods, “Gastrointestinal satiety signals. I. An overview of gastrointestinal signals that influence food intake,” American Journal of Physiology, vol. 286, no. 1, pp. G7–G13, 2004. View at Scopus
  17. C.-Y. Chen, M. Fujimiya, A. Asakawa, S.-D. Lee, and A. Inui, “Regulation of ingestive behavior, the upper gastrointestinal motility and gastric acid secretion by ghrelin in mammals,” Current Nutrition and Food Science, vol. 4, no. 1, pp. 32–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Stengel, A. Wisser, P. Kobelt, et al., “987 des-acyl ghrelin suppresses food intake and body weight gain in adult obese Zucker rats,” Gastroenterology, vol. 134, no. 4, supplement 1, p. A-148, 2008.
  19. A. Asakawa, A. Inui, M. Fujimiya, et al., “Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin,” Gut, vol. 54, no. 1, pp. 18–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Ariyasu, K. Takaya, H. Iwakura, et al., “Transgenic mice overexpressing des-acyl ghrelin show small phenotype,” Endocrinology, vol. 146, no. 1, pp. 355–364, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. N. M. Thompson, D. A. S. Gill, R. Davies, et al., “Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor,” Endocrinology, vol. 145, no. 1, pp. 234–242, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Kiewiet, M. O. van Aken, K. van der Weerd, et al., “Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes,” European Journal of Endocrinology, vol. 161, no. 4, pp. 567–573, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Bedendi, G. Alloatti, A. Marcantoni, et al., “Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin,” European Journal of Pharmacology, vol. 476, no. 1-2, pp. 87–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Baldanzi, N. Filigheddu, S. Cutrupi, et al., “Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT,” Journal of Cell Biology, vol. 159, no. 6, pp. 1029–1037, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Filigheddu, V. F. Gnocchi, M. Coscia, et al., “Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells,” Molecular Biology of the Cell, vol. 18, no. 3, pp. 986–994, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Kirchner, J. A. Gutierrez, P. J. Solenberg, et al., “GOAT links dietary lipids with the endocrine control of energy balance,” Nature Medicine, vol. 15, no. 7, pp. 741–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Toshinai, H. Yamaguchi, Y. Sun, et al., “Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor,” Endocrinology, vol. 147, no. 5, pp. 2306–2314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. V. Zhang, P.-G. Ren, O. Avsian-Kretchmer, et al., “Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake,” Science, vol. 310, no. 5750, pp. 996–999, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J. V. Zhang, H. Jahr, C.-W. Luo, et al., “Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39,” Molecular Endocrinology, vol. 22, no. 6, pp. 1464–1475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Jacques, B. Nawel, D. Roland, et al., “Role of the ghrelin/obestatin balance in the regulation of neuroendocrine circuits controlling body composition and energy homeostasis,” Molecular and Cellular Endocrinology, vol. 314, no. 2, pp. 244–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Xin, A.-J. Ren, X. Zheng, et al., “Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia,” Peptides, vol. 30, no. 12, pp. 2281–2285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Aygen, A. Dogukan, F. E. Dursun, et al., “Ghrelin and obestatin levels in end-stage renal disease,” Journal of International Medical Research, vol. 37, no. 3, pp. 757–765, 2009. View at Scopus
  33. V. P. Carlini, H. B. Schiöth, and S. R. DeBarioglio, “Obestatin improves memory performance and causes anxiolytic effects in rats,” Biochemical and Biophysical Research Communications, vol. 352, no. 4, pp. 907–912, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. W. K. Samson, M. M. White, C. Price, and A. V. Ferguson, “Obestatin acts in brain to inhibit thirst,” American Journal of Physiology, vol. 292, no. 1, pp. R637–R643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. S. L. Dun, G. C. Brailoiu, E. Brailoiu, J. Yang, J. K. Chang, and N. J. Dun, “Distribution and biological activity of obestatin in the rat,” Journal of Endocrinology, vol. 191, no. 2, pp. 481–489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. J. P. Camiña, J. F. Campos, J. E. Caminos, C. Dieguez, and F. F. Casanueva, “Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms,” Journal of Cellular Physiology, vol. 211, no. 1, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Szentirmai and J. M. Krueger, “Obestatin alters sleep in rats,” Neuroscience Letters, vol. 404, no. 1-2, pp. 222–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Szentirmai, L. Kapás, Y. Sun, R. G. Smith, and J. M. Krueger, “The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, pp. 14069–14074, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Yang, M. S. Brown, G. Liang, N. V. Grishin, and J. L. Goldstein, “Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone,” Cell, vol. 132, no. 3, pp. 387–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. J. A. Gutierrez, P. J. Solenberg, D. R. Perkins, et al., “Ghrelin octanoylation mediated by an orphan lipid transferase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 17, pp. 6320–6325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Gardiner and S. Bloom, “Ghrelin gets its GOAT,” Cell Metabolism, vol. 7, no. 3, pp. 193–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Tai, R. Visvanathan, A. J. Hammond, J. M. Wishart, M. Horowitz, and I. M. Chapman, “Fasting ghrelin is related to skeletal muscle mass in healthy adults,” European Journal of Nutrition, vol. 48, no. 3, pp. 176–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Nass, S. S. Pezzoli, M. C. Oliveri, et al., “Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial,” Annals of Internal Medicine, vol. 149, no. 9, pp. 601–611, 2008. View at Scopus
  44. E. R. Ayala, R. Pecoits-Filho, O. Heimburger, B. Lindholm, L. Nordfors, and P. Stenvinkel, “Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study,” Nephrology Dialysis Transplantation, vol. 19, no. 2, pp. 421–426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Barazzoni, A. Bosutti, M. Stebel, et al., “Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle,” American Journal of Physiology, vol. 288, no. 1, pp. E228–E235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Otero, R. Nogueiras, F. Lago, C. Dieguez, J. J. Gomez-Reino, and O. Gualillo, “Chronic inflammation modulates ghrelin levels in humans and rats,” Rheumatology, vol. 43, no. 3, pp. 306–310, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. L. D. Madison, J. M. Scarlett, P. Levasseur, et al., “Prostacyclin signaling regulates circulating ghrelin during acute inflammation,” Journal of Endocrinology, vol. 196, no. 2, pp. 263–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Pérez-Fontán, F. Cordido, A. Rodríguez-Carmona, J. Peteiro, R. García-Naveiro, and J. García-Buela, “Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis,” Nephrology Dialysis Transplantation, vol. 19, no. 8, pp. 2095–2100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Szczepańska, K. Szprynger, B. Mazur, D. Zwolińska, K. Kiliś-Pstrusińska, and I. Makulska, “Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis,” Peritoneal Dialysis International, vol. 27, no. 1, pp. 61–66, 2007. View at Scopus
  50. P. Iglesias, J. J. Díez, M. J. Fernández-Reyes, et al., “Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis,” Clinical Endocrinology, vol. 64, no. 1, pp. 68–73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Hosoda, M. Kojima, H. Matsuo, and K. Kangawa, “Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue,” Biochemical and Biophysical Research Communications, vol. 279, no. 3, pp. 909–913, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Yoshimoto, K. Mori, A. Sugawara, et al., “Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Plasma ghrelin and desacyl ghrelin concentrations in renal failure,” Journal of the American Society of Nephrology, vol. 13, no. 11, pp. 2748–2752, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Akamizu, T. Shinomiya, T. Irako, et al., “Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 6–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Pérez-Fontán, F. Cordido, A. Rodríguez-Carmona, et al., “Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure,” Kidney International, vol. 68, no. 6, pp. 2877–2885, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Conjard, B. Ferrier, M. Martin, A. Caillette, H. Carrier, and G. Baverel, “Effects of chronic renal failure on enzymes of energy metabolism in individual human muscle fibers,” Journal of the American Society of Nephrology, vol. 6, no. 1, pp. 68–74, 1995. View at Scopus
  56. I. M. Wahba and R. H. Mak, “Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 3, pp. 550–562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. R. H. Mak, “Insulin and its role in chronic kidney disease,” Pediatric Nephrology, vol. 23, no. 3, pp. 355–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Barazzoni, M. Zanetti, M. R. Cattin, et al., “Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats,” Obesity, vol. 15, no. 11, pp. 2614–2623, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Barazzoni, M. Zanetti, C. Ferreira, et al., “Relationships between deacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome,” Clinical Nutrition, vol. 27, no. 1, pp. 142–149, 2008.
  60. R. Barazzoni, X. X. Zhu, M. DeBoer, et al., “Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease,” Kidney International, vol. 77, no. 1, pp. 23–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. A. M. Wren, C. J. Small, C. R. Abbott, et al., “Ghrelin causes hyperphagia and obesity in rats,” Diabetes, vol. 50, no. 7–12, pp. 2540–2547, 2001. View at Scopus
  62. A. M. Wren, L. J. Seal, M. A. Cohen, et al., “Ghrelin enhances appetite and increases food intake in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5992–5995, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. W. G. Li, D. Gavrila, X. Liu, et al., “Ghrelin inhibits proinflammatory responses and nuclear factor-κB activation in human endothelial cells,” Circulation, vol. 109, pp. 2221–2226, 2004.
  64. V. D. Dixit, E. M. Schaffer, R. S. Pyle, et al., “Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells,” Journal of Clinical Investigation, vol. 114, no. 1, pp. 57–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. V. D. Dixit and D. D. Taub, “Ghrelin and immunity: a young player in an old field,” Experimental Gerontology, vol. 40, no. 11, pp. 900–910, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Date, N. Murakami, K. Toshinai, et al., “The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats,” Gastroenterology, vol. 123, no. 4, pp. 1120–1128, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Wu, W. Dong, X. Cui, et al., “Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve,” Annals of Surgery, vol. 245, no. 3, pp. 480–486, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. M. D. DeBoer, X. X. Zhu, P. Levasseur, et al., “Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia,” Endocrinology, vol. 148, no. 6, pp. 3004–3012, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. M. D. DeBoer, X. Zhu, P. R. Levasseur, et al., “Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile,” Endocrinology, vol. 149, no. 2, pp. 827–835, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Wynne, K. Giannitsopoulou, C. J. Small, et al., “Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial,” Journal of the American Society of Nephrology, vol. 16, no. 7, pp. 2111–2118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. D. R. Ashby, H. E. Ford, K. J. Wynne, et al., “Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment,” Kidney International, vol. 76, no. 2, pp. 199–206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. R. A. Femia and R. E. Goyette, “The science of megestrol acetate delivery: potential to improve outcomes in cachexia,” BioDrugs, vol. 19, no. 3, pp. 179–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Murata, Y. Okimura, K. Iida, et al., “Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells,” The Journal of Biological Chemistry, vol. 277, no. 7, pp. 5667–5674, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. A. D. Patel, S. A. Stanley, K. G. Murphy, et al., “Ghrelin stimulates insulin-induced glucose uptake in adipocytes,” Regulatory Peptides, vol. 134, no. 1, pp. 17–22, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Theander-Carrillo, P. Wiedmer, P. Cettour-Rose, et al., “Ghrelin action in the brain controls adipocyte metabolism,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1983–1993, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Choi, S.-G. Roh, Y.-H. Hong, et al., “The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis,” Endocrinology, vol. 144, no. 3, pp. 754–759, 2003. View at Publisher · View at Google Scholar · View at Scopus